Amarin’s Bold Moves Cement Future in Global Market with Strategic Maneuvers
Amarin Corporation’s strategic focus for 2024 emphasizes global expansion and innovation in the pharmaceutical industry. Their cornerstone product, VASCEPA, is backed by robust scientific data, generating over $200 million in revenue with nearly $300 million in cash reserves. VASCEPA has regulatory approval
